Starting January 1, 2006 people with severe acne who need Accutane (isotretinoin), must enroll in the FDA’s new iPLEDGE program through a physician who is also enrolled. In an effort to reduce the number of birth defects caused by isotretinoin, these new rules require anyone involved in the use or distribution of Accutane to be […]